Clinical trial
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
NCT00498628 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00498628 |
|---|---|
| Title | Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency |
| Official title | A Phase 2, Double-Blind, Placebo Controlled Trial to Assess the Efficacy of Quetiapine Fumarate Extended Release for the Treatment of Alcohol Dependence in Very Heavy Drinkers. |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH AstraZeneca Industry US Department of Veterans Affairs U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Alcohol Abuse |
| Intervention type | Drug, Other |
| Interventions | Quetiapine fumarate, Placebo |
| Enrollment | 224 |
| Start date | Dec 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Jul 10, 2007 |
| Last update posted | Mar 19, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: